VentriPoint Diagnostics Ltd. (VPT.V) said that Mayo Clinic has joined its multi-centre clinical trial to evaluate the use of an ultrasound diagnostic tool for patients with pulmonary arterial hypertension. Robert Frantz, M.D., a consultant in the Cardiovascular Division and Associate Professor of Medicine, College of Medicine, Mayo Clinic is the lead investigator for the clinical trial site in Rochester, MN.
The VMS is for investigational use only in the United States and is approved for sale and clinical use in Canada and Europe. VentriPoint is pursuing US-FDA approval through the 510(k) process.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.